Welcome to the CARDIOCARE project.

An interdisciplinary approach for the management of the elderly multimorbid patient with breast cancer therapy induced cardiac toxicity:  Aged-related factors and co-morbidities increase elderly breast cancer patients’ vulnerability to cardiotoxicity due to cancer treatment. Lack of best practices and frailty bias in these patients, underrepresented in trials, may lead to inappropriate interventions and undertreatment, resulting in poorer outcomes, deterioration of QoL, and increased healthcare costs. The EU-funded CARDIOCARE project will focus on the elderly breast cancer population and through a holistic approach including eHealth applications, wearable sensors and biomarkers will provide the ability to patients to take part in their care process and enhance their physical and mental health, contributing to an individualised care plan and a psychological adaptation to their disease. CARDIOCARE will enable effective risk stratification mitigating cardiotoxicity and adverse events, minimizing hospitalisation, and enhancing QoL